Skip to main content

Table 3 Outlets in remote areas and non-remote areas with quality-assured artemisinin combination therapies in stock at endline in Ghana and Kenya, 2011–2012

From: The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?

Country/Type of outlet

Remote areas

Non-remote areas

p value*

Percentage (95 % CI)

N

Percentage (95 % CI)

N

All QAACTs

 Ghana, total

77.9 (67.0–85.9)

149

83.8 (78.8–87.8)

487

0.1634

  Public health facility

96.2 (74.5–99.5)

26

80.0 (63.6–90.1)

55

0.0645

  Private not-for-profit health facilitya

100.0

4

90.0 (57.5–98.4)

10

  Private for-profit outlet

68.0 (47.6–83.3)

97

84.1 (78.5–88.5)

422

<0.0001

  Community health workera

95.5 (80.0–99.1)

22

0

 Kenya, total

56.2 (43.4–68.2)

392

70.8 (63.8–76.8)

1223

<0.0001

  Public health facility

95.4 (82.2–98.9)

51

96.4 (89.9–98.8)

105

0.9999

  Private not-for-profit health facilitya

100.0

15

98.6 (93.1–99.7)

43

0.561

  Private for-profit outlet

45.9 (30.0–62.6)

325

65.5 (57.2–72.9)

1075

<0.0001

  Community health workera

100.0

1

0

QAACTs with AMFm Logo

 Ghana, total

60.4 (37.7–79.3)

149

81.5 (76.7–85.6)

487

<0.0001

  Public health facility

84.6 (65.6–94.1)

26

76.4 (59.4–87.7)

55

0.3951

  Private not-for-profit health facilitya

100.0

4

80.0 (49.4–94.2)

10

  Private for-profit outlet

66.0 (45.9–81.6)

97

82.2 (76.9–86.5)

422

<0.0001

  Community health workera

0.0

22

 

0

 Kenya, total

48.5 (36.2–61.0)

392

64.0 (56.3–71.0)

1223

<0.0001

  Public health facility

60.5 (44.6–74.4)

51

68.9 (54.0–80.8)

105

0.9913

  Private not-for-profit health facility

73.3 (44.0–90.6)

15

58.8 (37.0–77.6)

43

0.3622

  Private for-profit outlet

44.9 (29.2–61.8)

325

63.5 (55.6–70.8)

1075

<0.0001

  Community health worker

100.0

1

0

  1. Percentages indicate the percentage of outlets in remote areas and non-remote areas that had quality-assured ACTs in stock at the time of the survey visit (n) among all outlets with any antimalarial in stock at the time of the survey visit (N), by type of outlet, according to country, 2011–2012. CI: Confidence interval; AMFm = Affordable Medicine Facility-malaria
  2. * p value for Chi square testing for difference between remote and non-remote areas
  3. aThese are presented in the table because they contribute to the country overall estimates; however, they are not discussed in the text because of the small sample